RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Don’t let winter ailments slow you down. Discover how understanding your symptoms can lead to powerful relief while embracing ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

Today, a new ESC Clinical Consensus Statement published in the European Heart Journal discusses the key role of vaccination ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Moderna shares rose on the increased effectiveness of its flu vaccine in late-stage trials, bring the biotech company closer ...

Moderna MRNA announced that its seasonal influenza vaccine candidate, mRNA-1010, achieved superior relative vaccine efficacy ...

Export volumes have been lower so far this year, but higher sales prices have more than made up for lower volumes.

HEALTH chiefs have warned of the danger of touching sick or dead wild birds – over risks of bird flu. In recent weeks, groups ...

Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose ...

Moderna’s mRNA flu shot outperforms existing vaccines in Phase 3 trial, showing over 26% greater efficacy—paving the way for ...

The Minister of Agriculture, John Steenhuisen, is pleased to announce that, in the coming days, South Africa will embark on its first-ever vaccination of poultry as a proactive measure to minimise the ...